February 9, 2018 / 12:50 AM / Updated 33 minutes ago

BRIEF-‍Pacific Biosciences Announces Outcome Of First Phase Of Patent Litigation Against Oxford Nanopore

Reuters Staff

1 Min Read

Feb 8 (Reuters) - Pacific Biosciences Of California Inc :

* ‍PACIFIC BIOSCIENCES ANNOUNCES OUTCOME OF FIRST PHASE OF PATENT LITIGATION AGAINST OXFORD NANOPORE

* PACIFIC BIOSCIENCES - ITC ‍TERMINATED INVESTIGATION INTO WHETHER OXFORD NANOPORE‘S MINION, PROMETHION DEVICES INFRINGE CLAIMS OF PATENTS OWNED BY CO Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

BRIEF-‍Pacific Biosciences Announces Outcome Of First Phase Of Patent Litigation Against Oxford Nanopore​

BRIEF-‍Pacific Biosciences Announces Outcome Of First Phase Of Patent Litigation Against Oxford Nanopore